Search

Search Results

1. Keverprazan Hydrochloride: First Approval

   Keverprazan hydrochloride (凯普拉生) is a potassium ion competitive acid blocker that is being developed by Jiangsu Carephar Pharmaceuticals for the...

   Connie Kang in Drugs

   Article 19 April 2023
   

2. Berdazimer Topical Gel, 10.3%: First Approval

   Berdazimer topical gel, 10.3% (ZELSUVMI™) is a nitric oxide (NO) releasing topical gel developed by Novan Inc. (a Ligand Pharmaceuticals company) for...

   Susan J. Keam in Drugs

   Article 27 February 2024
   

3. Nadofaragene Firadenovec: First Approval

   Nadofaragene firadenovec (nadofaragene firadenovec-vncg; Adstiladrin ^® ) is a non-replicating adenoviral vector-based gene therapy developed by Ferring...

   Arnold Lee in Drugs

   Article Open access 01 March 2023
   

4. Knowledge map** of biological disease-modifying anti-rheumatic drugs for axial spondyloarthritis: a bibliometric study

   Various biological disease-modifying anti-rheumatic drugs (bDMARDs) have been applied for treating axial spondyloarthritis (axSpA). However, there is...

   Qian He, Jia-qi Chen, ... Qing-wen Tao in Clinical Rheumatology

   Article 27 February 2023
   

5. Randomly controlled drivers using minimally invasive sampling: assessment of drug prevalence in Western Switzerland over two time periods

   Background

   According to the World Health Organization, road traffic injuries lead to 1.3 million deaths each year and represent the leading cause of...

   Timothée Joye, Julien Déglon, ... Aurélien Thomas in BMC Public Health

   Article Open access 28 December 2022
   

6. Sodium Phenylbutyrate and Ursodoxicoltaurine: First Approval

   An oral, fixed-dose coformulation of sodium phenylbutyrate and ursodoxicoltaurine (ALBRIOZA ^™ ; hereafter denoted sodium...

   Young-A Heo in CNS Drugs

   Article 30 July 2022
   

7. Pozelimab: First Approval

   Pozelimab (pozelimab-bbfg; VEOPOZ™) is a fully human immunoglobulin (Ig) G4 ^P (i.e. IgG4 with a proline substitution to promote stabilization of the...

   Sheridan M. Hoy in Drugs

   Article 19 October 2023
   

8. Acthar^® Gel Treatment for Patients with Autoimmune and Inflammatory Diseases: An Historical Perspective and Characterization of Clinical Evidence

   Acthar ^® Gel (repository corticotropin injection) is a naturally sourced complex mixture of adrenocorticotropic hormone analogs and other pituitary...

   Jeffrey Kaplan, Anca Askanase, ... Mehdi Mirsaeidi in Clinical Drug Investigation

   Article Open access 04 October 2023
   

9. Matrix analyses of pharmaceutical products for the years 2017 to 2019 among public health facilities in Hadiya zone, Ethiopia: a cross-sectional descriptive study

   Background

   To date, global healthcare spending becomes a primary concern, and pharmaceutical costs are the main drivers. The issue is more pressing in...

   Tamirat Yohannes, Bekele Boche, ... Tadesse Gudeta in BMC Health Services Research

   Article Open access 07 February 2022
   

10. Lotilaner Ophthalmic Solution 0.25%: First Approval

    Lotilaner ophthalmic solution 0.25% (XDEMVY™), a gamma-aminobutyric acid-gated chloride channel (GABA-Cl) inhibitor selective for mites, is being...

    Yahiya Y. Syed in Drugs

    Article Open access 16 October 2023
    

11. “The climate itself must have hidden some medicines”: traditional veterinary medicine of indigenous and non-indigenous campesinos of the southern Andes

    Background

    Traditional veterinary medicine (TVM) or ethnoveterinary medicine comprises knowledge, practices, and beliefs about farm animals. Its study...

    Fernanda Olivares, Carla Marchant, José Tomás Ibarra in Journal of Ethnobiology and Ethnomedicine

    Article Open access 03 May 2022
    

12. Exploring the effectiveness of demand-side retail pharmaceutical expenditure reforms

    Increasing expenditures on retail pharmaceuticals bring a critical challenge to the financial stability of healthcare systems worldwide. Policy...

    Michael Berger, Markus Pock, ... Thomas Czypionka in International Journal of Health Economics and Management

    Article Open access 21 September 2022
    

13. Neuroimaging Pharmacopoeia

    This book, now in a revised and updated second edition, reviews the imaging-relevant features of selected classes of pharmaceuticals and drugs...

    Daniel Thomas Ginat, Juan E. Small, Pamela Whitney Schaefer

    Book 2022
    

14. Two-year follow-up of a clustered randomised controlled trial of a multicomponent general practice intervention for people at risk of poor health outcomes

    Background

    This study was a two-year follow-up evaluation of health service use and the cost-effectiveness of a multicomponent general practice...

    Richard L. Reed, Leigh Roeger, Billingsley Kaambwa in BMC Health Services Research

    Article Open access 19 April 2024
    

15. Drivers of vulnerability to medicine smuggling and combat strategies: a qualitative study based on online news media analysis in Iran

    Background

    Medicine smuggling poses a serious public health threat, limiting patients’ safe and timely access to this essential resource. Thus, this...

    NourolHoda Fakhrzad, Vahid Yazdi-Feyzabadi, Maryam Fakhrzad in BMC Health Services Research

    Article Open access 27 March 2024
    

16. Gepirone Extended-Release: First Approval

    Gepirone HCL extended-release (gepirone ER; EXXUA™), an oral, selective serotonin (5HT)1A receptor agonist formulated for once-daily administration,...

    Susan J. Keam in Drugs

    Article 11 December 2023
    

17. Sodium Thiosulfate: Pediatric First Approval

    Sodium thiosulfate (Pedmark ^® ) is a chemoprotectant/antioxidant developed by Fennec Pharmaceuticals (formerly Adherex Technologies) to reduce to risk...

    Sohita Dhillon in Pediatric Drugs

    Article 15 December 2022
    

18. Are Medical Device Characteristics Included in HTA Methods Guidelines and Reports? A Brief Review

    It is well accepted that medical devices (MDs) and procedures have several unique characteristics compared with pharmaceuticals, such as learning...

    Rituparna Basu, Simon Eggington, ... Liesl Strachan in Applied Health Economics and Health Policy

    Article 04 July 2024
    

19. Landscape and challenges in economic evaluations of artificial intelligence in healthcare: a systematic review of methodology

    Background

    The potential for artificial intelligence (AI) to transform healthcare cannot be ignored, and the development of AI technologies has...

    Nanna Kastrup, Annette W. Holst-Kristensen, Jan B. Valentin in BMC Digital Health

    Article Open access 01 July 2024
    

20. Clazosentan: First Approval

    Clazosentan (PIVLAZ ^™ ) is a small molecule, endothelin (ET) A receptor-selective antagonist being developed by Idorsia Pharmaceuticals. ET _A receptor...

    Arnold Lee in Drugs

    Article 01 April 2022